![](/img/cover-not-exists.png)
Efficacy and safety of lipegfilgrastim versus pegfilgrastim: a randomized, multicenter, active-control phase 3 trial in patients with breast cancer receiving doxorubicin/docetaxel chemotherapy
Bondarenko, Igor, Gladkov, Oleg A, Elsaesser, Reiner, Buchner, Anton, Bias, PeterVolume:
13
Language:
english
Journal:
BMC Cancer
DOI:
10.1186/1471-2407-13-386
Date:
December, 2013
File:
PDF, 379 KB
english, 2013